Form EFFECT Applied Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 6, 2026 |
| Accession Number: | 0001193125-26-035517 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KBRA Assigns Senior Unsecured Debt Rating to Ripple Prime CIV US BD HoldCo LLC
- Sprinklr Named a Leader in 2026 Gartner® Magic Quadrant™ for Social Media Management and Listening
- SPX Technologies to Report Second Quarter 2026 Financial Results
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
